Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.

Orrù CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, Groveman BR, Edland SD, Safar JG, Lin JH, Caughey B, Geschwind MD, Sigurdson CJ.

MBio. 2018 Nov 20;9(6). pii: e02095-18. doi: 10.1128/mBio.02095-18.

2.

Prion Diseases.

Tee BL, Longoria Ibarrola EM, Geschwind MD.

Neurol Clin. 2018 Nov;36(4):865-897. doi: 10.1016/j.ncl.2018.07.005. Review.

PMID:
30366560
3.

Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.

Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, Calero M, Collins SJ, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F.

Mol Neurobiol. 2018 Jul 30. doi: 10.1007/s12035-018-1251-1. [Epub ahead of print]

PMID:
30062673
4.

Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F.

Shanbhag NM, Geschwind MD, DiGiovanna JJ, Groden C, Godfrey R, Yousefzadeh MJ, Wade EA, Niedernhofer LJ, Malicdan MCV, Kraemer KH, Gahl WA, Toro C.

Neurol Genet. 2018 Jun 8;4(3):e240. doi: 10.1212/NXG.0000000000000240. eCollection 2018 Jun.

5.

Differential diagnosis with other rapid progressive dementias in human prion diseases.

Geschwind MD, Murray K.

Handb Clin Neurol. 2018;153:371-397. doi: 10.1016/B978-0-444-63945-5.00020-9. Review.

PMID:
29887146
6.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 May 18. doi: 10.1093/brain/awy109. [Epub ahead of print]

7.

Expanding the global prevalence of spinocerebellar ataxia type 42.

Ngo K, Aker M, Petty LE, Chen J, Cavalcanti F, Nelson AB, Hassin-Baer S, Geschwind MD, Perlman S, Italiano D, Laganà A, Cavallaro S, Coppola G, Below JE, Fogel BL.

Neurol Genet. 2018 Apr 5;4(3):e232. doi: 10.1212/NXG.0000000000000232. eCollection 2018 Jun. No abstract available. Erratum in: Neurol Genet. 2018 May 18;4(3):e238.

8.

Prion disease.

Takada LT, Kim MO, Metcalf S, Gala II, Geschwind MD.

Handb Clin Neurol. 2018;148:441-464. doi: 10.1016/B978-0-444-64076-5.00029-6. Review.

PMID:
29478593
9.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group .

Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.

10.

Neuroimaging in Dementia.

Staffaroni AM, Elahi FM, McDermott D, Marton K, Karageorgiou E, Sacco S, Paoletti M, Caverzasi E, Hess CP, Rosen HJ, Geschwind MD.

Semin Neurol. 2017 Oct;37(5):510-537. doi: 10.1055/s-0037-1608808. Epub 2017 Dec 5. Review. No abstract available.

11.

Dystonia and ataxia progression in spinocerebellar ataxias.

Kuo PH, Gan SR, Wang J, Lo RY, Figueroa KP, Tomishon D, Pulst SM, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, Geschwind MD, Xia G, Subramony SH, Ashizawa T, Kuo SH.

Parkinsonism Relat Disord. 2017 Dec;45:75-80. doi: 10.1016/j.parkreldis.2017.10.007. Epub 2017 Oct 23.

12.

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.

Gan SR, Wang J, Figueroa KP, Pulst SM, Tomishon D, Lee D, Perlman S, Wilmot G, Gomez CM, Schmahmann J, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, Geschwind MD, Xia G, Subramony SH, Ashizawa T, Kuo SH.

Tremor Other Hyperkinet Mov (N Y). 2017 Oct 9;7:492. doi: 10.7916/D8GM8KRH. eCollection 2017.

13.

Mass Confusion.

Abad CL, Dhaliwal G, Geschwind MD, Saint S, Safdar N.

J Hosp Med. 2017 Sep;12(9):750-754. doi: 10.12788/jhm.2805. No abstract available.

PMID:
28914282
14.

Genetic PrP Prion Diseases.

Kim MO, Takada LT, Wong K, Forner SA, Geschwind MD.

Cold Spring Harb Perspect Biol. 2018 May 1;10(5). pii: a033134. doi: 10.1101/cshperspect.a033134. Review.

PMID:
28778873
15.

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Erkkinen MG, Kim MO, Geschwind MD.

Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4). pii: a033118. doi: 10.1101/cshperspect.a033118. Review.

PMID:
28716886
16.

Egocentric and allocentric visuospatial working memory in premotor Huntington's disease: A double dissociation with caudate and hippocampal volumes.

Possin KL, Kim H, Geschwind MD, Moskowitz T, Johnson ET, Sha SJ, Apple A, Xu D, Miller BL, Finkbeiner S, Hess CP, Kramer JH.

Neuropsychologia. 2017 Jul 1;101:57-64. doi: 10.1016/j.neuropsychologia.2017.04.022. Epub 2017 Apr 17.

17.

Precipitous Deterioration of Motor Function, Cognition, and Behavior.

Fernández-Fournier M, Perry DC, Tartaglia MC, de May M, Boxer A, Coppola G, Christine CW, Huang EJ, Seeley WW, Miller BL, DeArmond SJ, Grinberg LT, Geschwind MD.

JAMA Neurol. 2017 May 1;74(5):591-596. doi: 10.1001/jamaneurol.2016.6159.

18.

Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Takada LT, Kim MO, Cleveland RW, Wong K, Forner SA, Gala II, Fong JC, Geschwind MD.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):36-69. doi: 10.1002/ajmg.b.32505. Review.

PMID:
27943639
19.

Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease.

Kim H, Kim JH, Possin KL, Winer J, Geschwind MD, Xu D, Hess CP.

Brain Imaging Behav. 2017 Oct;11(5):1365-1372. doi: 10.1007/s11682-016-9616-4.

20.

Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

Fong JC, Rojas JC, Bang J, Legati A, Rankin KP, Forner S, Miller ZA, Karydas AM, Coppola G, Grouse CK, Ralph J, Miller BL, Geschwind MD.

J Alzheimers Dis. 2017;55(1):249-258.

21.

A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia.

Coulthart MB, Geschwind MD, Qureshi S, Phielipp N, Demarsh A, Abrams JY, Belay E, Gambetti P, Jansen GH, Lang AE, Schonberger LB.

Brain. 2016 Oct;139(Pt 10):2609-2616.

22.

Dementia.

Ljubenkov PA, Geschwind MD.

Semin Neurol. 2016 Aug;36(4):397-404. doi: 10.1055/s-0036-1585096. Epub 2016 Sep 19. Review.

23.

MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.

Biswas MHU, Almeida S, Lopez-Gonzalez R, Mao W, Zhang Z, Karydas A, Geschwind MD, Biernat J, Mandelkow EM, Futai K, Miller BL, Gao FB.

Stem Cell Reports. 2016 Sep 13;7(3):316-324. doi: 10.1016/j.stemcr.2016.08.006. Epub 2016 Sep 1.

24.

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Carlozzi NE, Schilling SG, Lai JS, Paulsen JS, Hahn EA, Perlmutter JS, Ross CA, Downing NR, Kratz AL, McCormack MK, Nance MA, Quaid KA, Stout JC, Gershon RC, Ready RE, Miner JA, Barton SK, Perlman SL, Rao SM, Frank S, Shoulson I, Marin H, Geschwind MD, Dayalu P, Goodnight SM, Cella D.

Qual Life Res. 2016 Oct;25(10):2441-2455. doi: 10.1007/s11136-016-1386-3. Epub 2016 Aug 13.

25.

Deutetrabenazine for Treatment of Chorea in Huntington Disease.

Geschwind MD, Paras N.

JAMA. 2016 Jul 5;316(1):33-5. doi: 10.1001/jama.2016.8011. No abstract available.

PMID:
27380339
26.

Rapidly Progressive Dementia.

Geschwind MD.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):510-37. doi: 10.1212/CON.0000000000000319. Review.

27.

Prion Diseases.

Geschwind MD.

Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38. doi: 10.1212/CON.0000000000000251. Review.

28.

Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis.

Ng AS, Kramer J, Centurion A, Dalmau J, Huang E, Cotter JA, Geschwind MD.

J Neuroimmunol. 2015 Oct 15;287:31-5. doi: 10.1016/j.jneuroim.2015.08.009. Epub 2015 Aug 8.

29.

Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.

Forner SA, Takada LT, Bettcher BM, Lobach IV, Tartaglia MC, Torres-Chae C, Haman A, Thai J, Vitali P, Neuhaus J, Bostrom A, Miller BL, Rosen HJ, Geschwind MD.

Neurol Clin Pract. 2015 Apr;5(2):116-125.

30.

Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease.

Rosenbloom MH, Tartaglia MC, Forner SA, Wong KK, Kuo A, Johnson DY, Colacurcio V, Andrews BD, Miller BL, DeArmond SJ, Geschwind MD.

Neurol Clin Pract. 2015 Apr;5(2):108-115.

31.

Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Cali I, Miller CJ, Parisi JE, Geschwind MD, Gambetti P, Schonberger LB.

Acta Neuropathol Commun. 2015 Jun 25;3:37. doi: 10.1186/s40478-015-0214-2.

32.

Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.

Watts JC, Giles K, Serban A, Patel S, Oehler A, Bhardwaj S, Guan S, Greicius MD, Miller BL, DeArmond SJ, Geschwind MD, Prusiner SB.

Ann Neurol. 2015 Oct;78(4):540-53. doi: 10.1002/ana.24463. Epub 2015 Aug 25.

33.

Clinical update of Jakob-Creutzfeldt disease.

Kim MO, Geschwind MD.

Curr Opin Neurol. 2015 Jun;28(3):302-10. doi: 10.1097/WCO.0000000000000197. Review.

PMID:
25923128
34.

White matter involvement in sporadic Creutzfeldt-Jakob disease.

Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto N, Oehler A, Miller BL, Lobach IV, Bastianello S, Geschwind MD, Henry RG.

Brain. 2014 Dec;137(Pt 12):3339-54. doi: 10.1093/brain/awu298. Epub 2014 Nov 2.

35.

Ascertainment bias causes false signal of anticipation in genetic prion disease.

Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD.

Am J Hum Genet. 2014 Oct 2;95(4):371-82. doi: 10.1016/j.ajhg.2014.09.003.

36.

Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state.

Zhang X, Lee SJ, Young KZ, Josephson DA, Geschwind MD, Wang MM.

Brain Res. 2014 Oct 2;1583:230-6. doi: 10.1016/j.brainres.2014.08.018. Epub 2014 Aug 21.

37.

Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.

Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM.

JAMA Neurol. 2014 Oct;71(10):1300-4. doi: 10.1001/jamaneurol.2014.1234.

38.

More than memory impairment in voltage-gated potassium channel complex encephalopathy.

Bettcher BM, Gelfand JM, Irani SR, Neuhaus J, Forner S, Hess CP, Geschwind MD.

Eur J Neurol. 2014 Oct;21(10):1301-10. doi: 10.1111/ene.12482. Epub 2014 Jul 1.

39.

Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD.

JAMA Neurol. 2014 Jul 1;71(7):896-900. doi: 10.1001/jamaneurol.2014.463.

40.

Quantitative 7T phase imaging in premanifest Huntington disease.

Apple AC, Possin KL, Satris G, Johnson E, Lupo JM, Jakary A, Wong K, Kelley DA, Kang GA, Sha SJ, Kramer JH, Geschwind MD, Nelson SJ, Hess CP.

AJNR Am J Neuroradiol. 2014 Sep;35(9):1707-13. doi: 10.3174/ajnr.A3932. Epub 2014 Apr 17.

41.

Application of quantitative DTI metrics in sporadic CJD.

Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD.

Neuroimage Clin. 2014 Jan 31;4:426-35. doi: 10.1016/j.nicl.2014.01.011. eCollection 2014.

42.

An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.

Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W, Pellegrini M, Horvath S, Miller BL, Geschwind DH, Coppola G.

PLoS Genet. 2014 Mar 6;10(3):e1004211. doi: 10.1371/journal.pgen.1004211. eCollection 2014 Mar.

43.

Doxycycline for Creutzfeldt-Jakob disease: a failure, but a step in the right direction.

Geschwind MD.

Lancet Neurol. 2014 Feb;13(2):130-2. doi: 10.1016/S1474-4422(14)70001-8. Epub 2014 Jan 8. No abstract available.

44.

Executive functions in premanifest Huntington's disease.

You SC, Geschwind MD, Sha SJ, Apple A, Satris G, Wood KA, Johnson ET, Gooblar J, Feuerstein JS, Finkbeiner S, Kang GA, Miller BL, Hess CP, Kramer JH, Possin KL.

Mov Disord. 2014 Mar;29(3):405-9. doi: 10.1002/mds.25762. Epub 2013 Dec 27.

45.

Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases.

Kim MO, Cali I, Oehler A, Fong JC, Wong K, See T, Katz JS, Gambetti P, Bettcher BM, Dearmond SJ, Geschwind MD.

Acta Neuropathol Commun. 2013 Dec 12;1:80. doi: 10.1186/2051-5960-1-80.

46.

Prion diseases.

Takada LT, Geschwind MD.

Semin Neurol. 2013 Sep;33(4):348-56. doi: 10.1055/s-0033-1359314. Epub 2013 Nov 14. Review.

PMID:
24234356
47.

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.

Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo SH, Geschwind MD, Xia G, Mazzoni P, Krischer JP, Cuthbertson D, Holbert AR, Ferguson JH, Pulst SM, Subramony SH.

Orphanet J Rare Dis. 2013 Nov 13;8:177. doi: 10.1186/1750-1172-8-177.

48.

Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.

Geschwind MD, Kuo AL, Wong KS, Haman A, Devereux G, Raudabaugh BJ, Johnson DY, Torres-Chae CC, Finley R, Garcia P, Thai JN, Cheng HQ, Neuhaus JM, Forner SA, Duncan JL, Possin KL, Dearmond SJ, Prusiner SB, Miller BL.

Neurology. 2013 Dec 3;81(23):2015-23. doi: 10.1212/WNL.0b013e3182a9f3b4. Epub 2013 Oct 11.

49.

Ethics in prion disease.

Bechtel K, Geschwind MD.

Prog Neurobiol. 2013 Nov;110:29-44. doi: 10.1016/j.pneurobio.2013.07.001. Epub 2013 Jul 29.

50.

Seizures and epileptiform activity in the early stages of Alzheimer disease.

Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L.

JAMA Neurol. 2013 Sep 1;70(9):1158-66. doi: 10.1001/jamaneurol.2013.136.

Supplemental Content

Loading ...
Support Center